The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1422
August 5, 2013
View Complete Issue         Table of Contents 2019 
Diclegis for Nausea and Vomiting of Pregnancy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Diclegis for Nausea and Vomiting of Pregnancy
August 5, 2013 (Issue: 1422)
The FDA has approved Diclegis (Duchesnay), a fixed-dose, delayed-release combination of the H1-antihistamine doxylamine and the vitamin B6 analog pyridoxine, for treatment of nausea and vomiting of pregnancy in women who do not respond to...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Diclegis for Nausea and Vomiting of Pregnancy
Article code: 1422a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.